An honest, interactive look at what lab, animal and human research says about fenbendazole – including the safety reports – so you can have an informed conversation with your oncologist.
Medically reviewed by Dr John Creek, MBBS · Updated 8 Oct 2026Tap each level of evidence, then test yourself with the myth-or-fact quiz.
No regulator has approved fenbendazole for people, and no clinical trial has established a safe or effective human dose for any cancer. Doses shared online come from anecdotes or animal products. Never stop or delay prescribed cancer treatment.
Tell your doctor about every supplement or non-prescribed medicine you take.
This guide summarises published research and is not medical advice. Evidence reviewed as of October 2026; check ClinicalTrials.gov for current studies.
Fenbendazole is a benzimidazole anthelmintic – a dewormer – used in dogs, cats, cattle, horses and other animals. It belongs to the same chemical family as mebendazole and albendazole, which are approved for treating worm infections in people. Fenbendazole itself is not approved for human use by the FDA in the US, the MHRA in the UK, the TGA in Australia or the European Medicines Agency.
Interest grew after a widely shared personal story in the late 2010s. The person involved was also receiving cancer treatment at the time, so the outcome cannot be credited to fenbendazole. Since then, the idea has spread through social media, forums and podcasts, often with dosing ‘protocols’ and ‘stacks’ that have never been tested in a clinical trial.
| Evidence level | What exists | What it means for patients |
|---|---|---|
| Lab (cell) studies | Effects on microtubules and glucose uptake in some cancer cell lines | An early signal only. Most compounds that work in a dish fail in people. |
| Animal studies | A few mouse studies with mixed results | Not enough to predict benefit or safety in humans. |
| Human case reports | Individual stories, usually alongside other treatment | Cannot show cause and effect. |
| Randomized clinical trials | No completed trials published | No reliable evidence that it treats cancer in people. |
| Regulatory approval | Veterinary use only | No approved human use and no established human dose. |
Case reports in medical journals describe drug-induced liver injury in people with cancer who took fenbendazole on their own, in some cases serious enough to interrupt their cancer treatment. Veterinary products are not manufactured or tested to human-medicine standards, so the dose and purity of what people take can vary. Fenbendazole may also interact with chemotherapy, immunotherapy or targeted drugs in ways that have never been studied, and extra liver strain can make standard treatment harder to continue.
Repurposing existing medicines for cancer is a real and active area of research. Approved drugs such as mebendazole are being studied in clinical trials, where doses, safety monitoring and interactions are carefully controlled and results are published. If this interests you, ask your oncologist about trials you may qualify for, or search ClinicalTrials.gov and the National Cancer Institute’s trial finder.
Many patients worry their doctor will dismiss them. It helps to be open: say what you have read, why it interests you, and ask what the evidence shows for your specific cancer. Use the printable checklist above, bring a full list of everything you take – including supplements – and ask whether an integrative oncology or supportive care service is available. Your care team can also check your liver function if you are concerned.
These are not cancer treatments. They are approved human benzimidazole and anti-parasitic medicines used for worm infections, shown here for people looking for licensed alternatives to veterinary dewormers.
There is no clinical trial evidence that fenbendazole cures or treats cancer in people. The evidence is limited to lab studies, some animal studies and individual anecdotes.
No. It is approved only as a veterinary dewormer. Related drugs, mebendazole and albendazole, are approved for worm infections in people.
There is no established human dose. Doses shared online come from anecdotes and have not been tested for safety or effectiveness.
Medical journals have reported liver injury in people who self-medicated with it. Its safety and interactions with cancer treatments have not been studied properly.
Do not combine it without your oncologist’s knowledge. Interactions have not been studied, and added liver strain could affect your treatment.
Both are benzimidazole dewormers. Mebendazole is approved for human worm infections and is being studied in early cancer trials; fenbendazole is approved only for animals.
Personal stories spread quickly, and people often take it alongside standard treatment, so improvements cannot be credited to fenbendazole. Stories where it did not help are rarely shared.
Yes. Search ClinicalTrials.gov or the National Cancer Institute trial finder, or ask your oncologist about trials of repurposed medicines where safety is monitored.
Tell your oncologist and pharmacist so they can check for interactions and monitor your liver function. Do not stop your prescribed cancer treatment.
Yellow skin or eyes, dark urine, pale stools, pain under the right ribs, unusual tiredness or nausea. Seek medical care promptly if you notice any of these.
Print the oncologist checklist and screen your other medicines.